TickrTrends COLL fair value analysis

A Look at Collegium Pharmaceutical Inc (COLL) After 3.9% Decline -- GF Value $47.17 vs Price $26.39

gurufocus.com · 2026-08-28

On August 27, 2026, Collegium Pharmaceutical Inc (COLL) shares fell 3.9% to a current price of $26.39. Over the past year, the stock has seen significant volati

TickrTrends take: Collegium Pharmaceutical trades significantly below its GF Value estimate, which aligns with TickrTrends' assessment that the stock is undervalued within the Healthcare sector. The gap between the valuation estimate and current price suggests the market may be pricing in concerns that a fundamental analysis does not fully support. Investors focused on valuation should monitor whether the company's operational performance and pipeline developments can justify closing this valuation gap over time.

Read the full story at gurufocus.com →

Is COLL undervalued? See TickrTrends' fair value analysis →